Pre-emptive intravenous ganciclovir versus valganciclovir prophylaxis for de novo cytomegalovirus-seropositive kidney-transplant recipients.

Weclawiak, Hugo

Pre-emptive intravenous ganciclovir versus valganciclovir prophylaxis for de novo cytomegalovirus-seropositive kidney-transplant recipients. [electronic resource] - Transplant international : official journal of the European Society for Organ Transplantation Oct 2010 - 1056-64 p. digital

Publication Type: Journal Article

1432-2277

10.1111/j.1432-2277.2010.01101.x doi


Adolescent
Adult
Aged
Antiviral Agents--therapeutic use
Child
Cohort Studies
Cytomegalovirus--genetics
Cytomegalovirus Infections--prevention & control
DNA, Viral--blood
Female
Ganciclovir--analogs & derivatives
Graft Rejection--prevention & control
Humans
Kidney Transplantation--methods
Male
Middle Aged
Retrospective Studies
Risk Factors
Valganciclovir
Virus Activation